Both in R&D — Physical & Biological Sciences
iSpecimen vs Charles River Laboratories International
Over the past year ISPC returned −97.3% and CRL returned +97.4%; their daily moves had a correlation of 0.07.
ISPC −97.3% CRL +97.4%Growth of $1, one year, split-adjusted
| Metric | ISPC | CRL |
|---|---|---|
| Price | $0.8200 | $353.12 |
| Market cap | $2.1M | $16.86B |
| Today | −1.48% | +4.31% |
| 1 month | −21.9% | +13.6% |
| 6 months | −86.2% | +90.5% |
| Year to date | −92.1% | +77.0% |
| 1 year | −97.4% | +96.1% |
| Revenue growth (YoY) | −78.7% | −2.7% |
| Gross margin | 45.2% | 36.2% |
| Net margin | −896.9% | −0.1% |
| P/E (TTM) | — | — |
| Price / sales | 4.4× | 4.2× |
| Net cash | $4.4M | -$2.43B |
| Dividend yield | — | — |
| Volatility (60d) | 84.5% | 41.6% |
| Short % of float | 10.4% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).